Prolonged or extended blockade (>7 days post-myocardial infarction) of S100A8/A9 has adverse effects, such as impaired monocyte/hematopoietic stem cell responses, reduced reparative/fibrotic macrophage recruitment, and deterioration of cardiac function (36, 51). This evidence concerns the gene S100A8 and myocardial infarction.